XTENT, Inc.
125 Constitution Drive
Menlo Park,
CA 94025
United States - Map
Phone: 650-475-9400
Fax: 650-475-9401
Web Site: http://www.xtentinc.com
| XTENT, Inc., a medical device company, focuses on the development and commercialization of drug eluting stent systems for the treatment of coronary artery disease. Its drug eluting stent systems are designed to enable physicians to customize length and diameter of the stent at the site of the diseased section of the artery or lesion. The company’s stent systems include Custom NX 36, which is used to treat single or multiple lesions; and Custom NX 60 that is used to treat one long lesion or multiple smaller lesions with the use of one device. It is also developing 36mm and 60mm stent systems based on its proprietary technology platform. The company was founded in 2002 and is based in Menlo Park, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Gregory D. Casciaro , 51
Chief Exec. Officer, Pres |
N/A
| N/A | Mr. Bernard H. Andreas , 50
Co-Founder and VP of R&D |
N/A
| N/A | Mr. Timothy D. Kahlenberg , 48
Chief Financial Officer and Principal Accounting Officer |
N/A
| N/A | Mr. Randolph E. Campbell , 51
Chief Technical Officer |
N/A
| N/A | Mr. Philippe H. Marco M.D., 44
VP of Quality Assurance, Clinical & Regulatory Affairs |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-07
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
2.63% Nasdaq 0.00%
Profile
